481 related articles for article (PubMed ID: 8505813)
1. Organ procurement expenditures and the role of financial incentives.
Evans RW
JAMA; 1993 Jun 23-30; 269(24):3113-8; discussion 3155-6. PubMed ID: 8505813
[TBL] [Abstract][Full Text] [Related]
2. Organ procurement: expenditures and financial incentives.
Sloan FA
JAMA; 1993 Jun 23-30; 269(24):3155-6. PubMed ID: 11652640
[TBL] [Abstract][Full Text] [Related]
3. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit.
Evans RW
Clin Transpl; 1993; ():359-91. PubMed ID: 7918169
[TBL] [Abstract][Full Text] [Related]
4. The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States.
Evans RW; Orians CE; Ascher NL
JAMA; 1992 Jan; 267(2):239-46. PubMed ID: 1727520
[TBL] [Abstract][Full Text] [Related]
5. Financial Incentives for Living Kidney Donors: Are They Necessary?
Martin DE; White SL
Am J Kidney Dis; 2015 Sep; 66(3):389-95. PubMed ID: 26060182
[TBL] [Abstract][Full Text] [Related]
6. Rethinking the national organ transplant program: when push comes to shove.
Sten JA
J Contemp Health Law Policy; 1994; 11(1):197-219. PubMed ID: 10142391
[No Abstract] [Full Text] [Related]
7. Costs associated with expanding donor criteria: a collaborative statewide prospective study.
Jacobbi LM; McBride V; Etheredge EE; McDonald JC; Feduska N; Frey DJ; Boudreaux JP; Van Meter C; McMillan R; Tesi RJ
Transplant Proc; 1997; 29(1-2):1550-6. PubMed ID: 9123422
[No Abstract] [Full Text] [Related]
8. Can we afford to transplant?
Mitchell SV; Smallwood RA; Angus PW; Lapsley HM
Med J Aust; 1993 Feb; 158(3):190-4. PubMed ID: 8450789
[No Abstract] [Full Text] [Related]
9. How dangerous are financial incentives to obtain organs?
Evans RW
Transplant Proc; 1999; 31(1-2):1337-41. PubMed ID: 10083594
[No Abstract] [Full Text] [Related]
10. Tissue transplants: the dilemma of the body's growing value.
Thorne ED
Public Interest; 1990; No. 98():37-48. PubMed ID: 11650342
[No Abstract] [Full Text] [Related]
11. Perspectives of transplant physicians and surgeons on reimbursement, compensation, and incentives for living kidney donors.
Tong A; Chapman JR; Wong G; Craig JC
Am J Kidney Dis; 2014 Oct; 64(4):622-32. PubMed ID: 24703962
[TBL] [Abstract][Full Text] [Related]
12. Estimates of organ-specific donor availability for the United States.
Orians CE; Evans RW; Ascher NL
Transplant Proc; 1993 Feb; 25(1 Pt 2):1541-2. PubMed ID: 8442181
[No Abstract] [Full Text] [Related]
13. Incentives for organ donation: pros and cons.
Chkhotua A
Transplant Proc; 2012; 44(6):1793-4. PubMed ID: 22841275
[TBL] [Abstract][Full Text] [Related]
14. The proposed market for human organs.
Spurr SJ
J Health Polit Policy Law; 1993; 18(1):189-202. PubMed ID: 8320438
[TBL] [Abstract][Full Text] [Related]
15. The UNOS OPTN Waiting List and Donor Registry: 1988-1996.
Harper AM; Rosendale JD
Clin Transpl; 1996; ():69-90. PubMed ID: 9286559
[TBL] [Abstract][Full Text] [Related]
16. National Organ Transplant Act: Public Law 98-507.
United States
US Statut Large; 1984 Oct; 98():2339-48. PubMed ID: 11660818
[No Abstract] [Full Text] [Related]
17. Financial incentives in organ donation: current issues.
Peters TG
Dial Transplant; 1992 May; 21(5):270, 273, 290. PubMed ID: 11654010
[No Abstract] [Full Text] [Related]
18. The meaning of "The economics and ethics of alternative cadaveric organ procurement policies.
Guttmann RD
Yale J Regul; 1991; 8(2):453-62. PubMed ID: 11652067
[No Abstract] [Full Text] [Related]
19. Is retransplantation cost effective?
Evans RW; Manninen DL; Dong FB; McLynne DA
Transplant Proc; 1993 Feb; 25(1 Pt 2):1694-6. PubMed ID: 8442240
[No Abstract] [Full Text] [Related]
20. Paid Living Donation and Growth of Deceased Donor Programs.
Ghahramani N
Transplantation; 2016 Jun; 100(6):1165-9. PubMed ID: 27203584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
